Article info
Review
Neuroleptic malignant syndrome in patients with cancer: a systematic review
- Correspondence to Dr Koji Kawakami, Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University Yoshida Konoecho, Kyoto 606-8501, Japan; kawakami.koji.4e{at}kyoto-u.ac.jp
Citation
Neuroleptic malignant syndrome in patients with cancer: a systematic review
Publication history
- Received January 11, 2020
- Revision received April 7, 2020
- Accepted April 20, 2020
- First published May 15, 2020.
Online issue publication
August 19, 2020
Article Versions
- Previous version (15 May 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.